Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
67 NC counties are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Closings
31 closings/delays reported.
Just In
Category 4: Hurricane Helene becomes Category 4 storm as it approaches landfall in Florida
Just In
Tornado warning: Tornado warning until 6:30 p.m. for Durham, Granville and Wake counties. Turn on WRAL-TV for the forecast.
Program
On WRAL at 7: The worst of Helene yet to come! Who could see the biggest risk for flooding and tornadoes and when
Program
On WRAL at 7:30: Alarming rise of teen vaping in NC, A WRAL Documentary on how harmful products are marketed to children.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
41.53
-0.42 (-1.00%)
Official Closing Price
Updated: 4:15 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
611,759
Open
42.00
Bid (Size)
41.61 (1)
Ask (Size)
44.40 (2)
Prev. Close
41.95
Today's Range
41.20 - 44.79
52wk Range
26.61 - 75.02
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rallies 28% On Upsized IPO
Today 13:18 EDT
The company is working on a drug that mimics apelin, which is released following exercise.
Via
Investor's Business Daily
Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
September 24, 2024
Novo Nordisk has received both good and bad news recently when it comes to weight loss and diabetes drugs. So, where does the firm stand now?
Via
MarketBeat
Performance
YTD
+2.82%
+2.82%
1 Month
+2.29%
+2.29%
3 Month
+9.64%
+9.64%
6 Month
-3.22%
-3.22%
1 Year
+22.69%
+22.69%
More News
Read More
Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer
September 17, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Peering Into Structure Therapeutics's Recent Short Interest
July 15, 2024
Via
Benzinga
Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review
September 13, 2024
Via
Investor's Business Daily
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
August 29, 2024
Via
Investor's Business Daily
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
August 27, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
August 26, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
3 Promising Biotech Stocks for the Long-Term: August 2024
August 13, 2024
Via
InvestorPlace
GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q2 2024
August 09, 2024
Via
InvestorPlace
Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
August 08, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
3 Biotech Stocks That Could Make Your Summer Unforgettable
July 30, 2024
Via
InvestorPlace
Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.
July 22, 2024
Via
The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
Via
Investor's Business Daily
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Via
Benzinga
ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
July 17, 2024
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
July 12, 2024
Via
InvestorPlace
Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
July 09, 2024
Via
MarketBeat
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Via
MarketBeat
Exposures
Product Safety
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
July 02, 2024
Via
MarketBeat
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
June 28, 2024
Via
InvestorPlace
Could Structure Therapeutics Become the Next Novo Nordisk?
June 17, 2024
Via
The Motley Fool
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
June 14, 2024
Via
Investor's Business Daily
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
June 11, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.